Neuren Pharmaceuticals Ltd (NEU) — Cash Flow Reinvestment Rate
Neuren Pharmaceuticals Ltd (NEU) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting AU$5.00K (capex AU$5.00K ) from operating cash flow of AU$128.31 Million. See Neuren Pharmaceuticals Ltd (NEU) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Neuren Pharmaceuticals Ltd Cash Flow Reinvestment Rate (2018–2023)
Historical reinvestment intensity for Neuren Pharmaceuticals Ltd across 3 annual periods. For the full cash flow conversion analysis, see NEU operating cash flow.
Annual Cash Flow Reinvestment Rate for Neuren Pharmaceuticals Ltd (2018–2023)
Year-by-year capital reinvestment analysis for Neuren Pharmaceuticals Ltd. See Neuren Pharmaceuticals Ltd (NEU) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.14x | AU$211.53 Million | AU$184.93 Million | AU$40.00K | ▲ +10733.4% |
| 2022 | 0.01x | AU$38.00K | AU$3.60 Million | AU$19.00K | ▲ +463.8% |
| 2018 | 0.00x | AU$12.00K | AU$6.41 Million | AU$12.00K | — |